Skip to content
Trial Eligibility
Menu

Vestibular Therapy in Alzheimer's Disease

NCT03799991

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Nearly 2 out of 3 patients with Alzheimer's disease (AD) experience problems with balance and mobility, which places such patients at increased risk of falling. The vestibular (inner ear balance) system plays an important role in balance stability, and vestibular therapy (VT) is well-known to improve balance function in healthy older adults. In this study, the investigators will conduct a first-in-kind randomized clinical trial to evaluate whether vestibular therapy improves reduces falls in patients with AD, in whom this treatment has never been studied.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Vestibular Diseases
  • Vestibular Disorder
  • Alzheimer Disease

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
60 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Johns Hopkins University
Last updated on ClinicalTrials.gov
January 12, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 1

  • Johns Hopkins University School of Medicine · Baltimore, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.